Rana Lonnen

Rana Lonnen is a prominent figure in the venture capital and biotechnology sectors, currently serving as the Managing Director of dRx Capital at Novartis since May 2017. Recently appointed as Head of S&E Strategic Venture Capital at Yseop in October 2023, Rana also holds multiple positions as an investor and board observer for various companies including Lightship, Octave, RxLightning Inc., Holmusk, H1, Koneksa, Mekonos Inc., and COTA, Inc. With an academic background that includes an MBA from Imperial College London and a PhD in Molecular Biology from the University of Leicester, Rana brings extensive expertise to the field of strategic investments and biotechnology innovation.